Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Targeting Vδ1+T-cells may help treat alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

CD4+ skin cells may be precursors to basal cell carcinoma.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The assay effectively identifies compounds that affect immune cell activation.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

IL-17-producing γδ T cells help improve bone healing.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Fetal skin has unique immune cells different from adult skin.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.